U.S. market Open. Closes in 43 minutes

LFCR | Lifecore Biomedical, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2024-05-262023-05-312023-05-282022-05-312022-05-292021-05-312020-05-312019-05-312018-05-31
Revenue128.26M103.27M103.27M185.79M185.79M544.16M590.37M557.56M524.23M
Cost of Revenue86.41M75.98M75.98M135.42M135.23M462.69M515.38M476.56M445.89M
Gross Profit41.85M27.29M27.29M50.37M50.55M81.47M74.99M81.00M78.34M
Operating Expenses49.04M51.26M51.26M53.97M50.47M75.59M83.29M75.53M64.75M
Selling, General & Admin40.46M43.02M43.02M46.13M42.63M65.36M72.19M64.06M51.95M
Research & Development8.57M8.24M8.24M7.84M7.84M10.22M11.10M11.47M12.80M
Other Operating Expenses-3.05M-729.00K-729.00K6.46M3.30M-12.80M-4.39M1.60M2.90M
Operating Income-7.19M-26.08M-26.08M-41.29M3.46M-6.86M-8.30M-8.01M11.85M
Other Expenses / Income16.70M-26.62M-26.62M-31.24M-55.38M-33.60M-43.01M11.65M12.11M
Before Tax Income9.51M-68.70M-68.70M-52.12M-51.92M-40.47M-51.31M3.64M16.40M
Income Tax Expenses183.00K301.00K301.00K-5.84M-5.84M-7.80M-13.12M1.52M-9.36M
Net Income12.01M-102.19M-102.19M-97.43M-46.08M-32.66M-38.19M2.12M24.83M
Interest Expenses18.09M18.18M18.18M17.36M17.26M15.34M9.60M5.23M1.95M
Basic Shares Outstanding30.47M29.96M29.96M29.51M29.47M29.29M29.16M28.36M27.70M
Diluted Shares Outstanding36.66M29.96M29.96M29.51M29.47M29.29M29.16M28.61M27.91M
EBITDA812.00K-11.12M-11.12M-68.03M21.25M13.00M-12.59M7.22M16.70M
EBITDA Margin0.63%-10.77%-10.77%-36.62%11.44%2.39%-2.13%1.29%3.19%
EBIT30.29M-83.70M-83.70M-85.91M-34.66M-25.12M-41.70M8.87M17.42M
EBIT Margin23.61%-81.06%-81.06%-46.24%-18.66%-4.62%-7.06%1.59%3.32%
Financial Year End2024-05-262023-05-312023-05-282022-05-312022-05-292021-05-312020-05-312019-05-312018-05-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙